With New Data, Lipella Plots 2025 Milestones For Oral Rinse Tacrolimus
Phase IIa Data Shows Statistically Significant Reductions In Pain, Ulceration, And Inflammation
Reformulation specialist Lipella has an eye on numerous milestones for its proposed oral rinse liposomal formulation of tacrolimus, including the submission of a Phase IIb clinical trial investigational new drug application.
